Vaccine Induced HIV Seropositivity/reactivity (VISP/R) among Recipients of Adenovirus Vectored HIV-1 Vaccine Prime/boost Regimens

被引:0
|
作者
Kitandwe, Paul [1 ]
Farah, Bashir [2 ]
Bizimana, Jean [3 ]
Karita, Etienne [3 ]
Mutua, Gaudensia [2 ]
Mpendo, Juliet [1 ]
Omosa-Manyonyi, Gloria [2 ]
Bekker, Linda-Gail [4 ]
Gray, Glenda [5 ]
Baden, Lindsey [6 ]
Lehrman, Jennifer [7 ]
Laufer, Dagna [7 ]
Roman, Francois [8 ]
Barin, Burc [9 ]
Schmidt, Claudia [7 ]
Fast, Patricia [7 ]
Cox, Josephine [7 ]
Priddy, Frances [7 ]
Gelderblom, Huub [7 ]
机构
[1] UVRI IAVI HIV Vaccine Program, Entebbe, Uganda
[2] Kenya AIDS Vaccine Initiat, Nairobi, Kenya
[3] Project San Francisco, Kigali, Rwanda
[4] Desmond Tutu HIV Ctr, Cape Town, South Africa
[5] Perinatal HIV Res Unit, Soweto, South Africa
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
[7] Int AIDS Vaccine Initiat IAVI, New York, NY USA
[8] GlaxoSmithKline Vaccines, Rixensart, Belgium
[9] EMMES Corp, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P25.12
引用
收藏
页码:394 / 394
页数:1
相关论文
共 50 条
  • [41] P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
    E Karita
    K Kayitenkore
    R Bayingana
    F Sebahungu
    J Bizimana
    K Grabowski
    A Tichacek
    C Schmidt
    P Fast
    E Hunter
    S Allen
    Retrovirology, 6
  • [42] Preexisting Immunity to Multiple Adenovirus Serotypes is Not Associated with Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials
    Stephenson, K. E.
    Hural, J.
    Buchbinder, S. P.
    Sinangil, F.
    Barouch, D. H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A132 - A133
  • [43] Lymphoproliferative responses induced by HIV-1 immunogen vaccine children with HIV infection.
    Ratto-Kim, S
    Robb, M
    Sandelli, S
    Williams, M
    Sei, S
    Theofan, G
    Diveley, J
    Moss, RB
    Venzon, D
    Wood, LV
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 220 - 220
  • [44] R Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations
    Lassauniere, Ria
    Tiemessen, Caroline T.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] HIV testing access outside a trial centre among vaccine recipients despite counselling on possible vaccine induced sero positivity (VISP): experience from a research centre in western Uganda
    Asio, D. J.
    Kibengo, F. Mukasa
    Chinyenze, K. V.
    Ding, S.
    Price, M.
    Kaleebu, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [46] Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
    Crooks, Emma T.
    Almanza, Francisco
    D'Addabbo, Alessio
    Duggan, Erika
    Zhang, Jinsong
    Wagh, Kshitij
    Mou, Huihui
    Allen, Joel D.
    Thomas, Alyssa
    Osawa, Keiko
    Korber, Bette T.
    Tsybovsky, Yaroslav
    Cale, Evan
    Nolan, John
    Crispin, Max
    Verkoczy, Laurent K.
    Binley, James M.
    PLOS PATHOGENS, 2021, 17 (10)
  • [48] HIV-1 infections during vaccine trials: Identifying new epitopes for differential diagnosis of HIV-1 infections in the face of vaccine-induced antibodies
    Golding, Hana
    Needham, James
    Khurana, Surender
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [49] Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
    Huang, Yunda
    Zhang, Yuanyuan
    Seaton, Kelly E.
    De Rosa, Stephen
    Heptinstall, Jack
    Carpp, Lindsay N.
    Randhawa, April Kaur
    McKinnon, Lyle R.
    McLaren, Paul
    Viegas, Edna
    Gray, Glenda E.
    Churchyard, Gavin
    Buchbinder, Susan P.
    Edupuganti, Srilatha
    Bekker, Linda-Gail
    Keefer, Michael C.
    Hosseinipour, Mina C.
    Goepfert, Paul A.
    Cohen, Kristen W.
    Williamson, Brian D.
    McElrath, M. Juliana
    Tomaras, Georgia D.
    Thakar, Juilee
    Kobie, James J.
    EBIOMEDICINE, 2022, 84
  • [50] Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine
    Sabbaj, S
    Mulligan, MJ
    Hsieh, RH
    Belshe, RB
    McGhee, JR
    AIDS, 2000, 14 (10) : 1365 - 1374